SA
Santhera Pharmaceuticals Holding AG
SANN.SW · SIX
CHF 15.80 -0.25% (-CHF 0.04)
1M -0.63%
Market Cap CHF 235.8M
P/E Ratio -
Div. Yield -
ROE 320.88%
Bulios Fair Price
CHF 21.95
38.9% upside
Trenutna cena
CHF 15.8
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SANN.SW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
57 /100
Fair P/S 3.06x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 117.78%
FCF growth N/A
Book val. growth N/A
Profitability
5 /100
Weak Net margin 63.79%
Op. margin 48.99%
FCF margin 45.11%
Quality
6 /100
Poor ROE 320.88%
ROA 33.25%
Asset turnover 0.52x
Debt
25 /100
High Int. coverage -3.27x
Current ratio 1.29x
Net debt/EBITDA N/A
Stability
13 /100
Unstable Rev. volatility 735.41%
EPS volatility 158.47%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SANN.SW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Orlando Oliveira
Employees
78
Headquarters
Pratteln
Prihajajoči dogodki
21 SEP.
Earnings
Upcoming earnings report